nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

Open Access 21.06.2017 | Review

Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review

verfasst von: F. Tagini, G. Greub

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2017

Abstract

In recent years, whole-genome sequencing (WGS) has been perceived as a technology with the potential to revolutionise clinical microbiology. Herein, we reviewed the literature on the use of WGS for the most commonly encountered pathogens in clinical microbiology laboratories: Escherichia coli and other Enterobacteriaceae, Staphylococcus aureus and coagulase-negative staphylococci, streptococci and enterococci, mycobacteria and Chlamydia trachomatis. For each pathogen group, we focused on five different aspects: the genome characteristics, the most common genomic approaches and the clinical uses of WGS for (i) typing and outbreak analysis, (ii) virulence investigation and (iii) in silico antimicrobial susceptibility testing. Of all the clinical usages, the most frequent and straightforward usage was to type bacteria and to trace outbreaks back. A next step toward standardisation was made thanks to the development of several new genome-wide multi-locus sequence typing systems based on WGS data. Although virulence characterisation could help in various particular clinical settings, it was done mainly to describe outbreak strains. An increasing number of studies compared genotypic to phenotypic antibiotic susceptibility testing, with mostly promising results. However, routine implementation will preferentially be done in the workflow of particular pathogens, such as mycobacteria, rather than as a broadly applicable generic tool. Overall, concrete uses of WGS in routine clinical microbiology or infection control laboratories were done, but the next big challenges will be the standardisation and validation of the procedures and bioinformatics pipelines in order to reach clinical standards.

Introduction

Over the last decade, whole-genome sequencing (WGS) has been identified as one of the most promising techniques in clinical microbiology [1, 2]. Since the first bacterial genomes sequenced in 1995 [3, 4], it has come a long way and genome sequencing is now broadly implemented in research laboratories thanks to the rise of high-throughput sequencing [5]. Although its use in clinical microbiology increases, WGS is differentially implemented depending on the pathogen or the intended uses. Generally, clinical microbiology aims to provide a rapid detection and identification of a microorganism, for bacteria, combined or not with antimicrobial susceptibility testing (AST). Recent improvements of sequencing technologies with higher speed and output-to-cost ratios render WGS applicable for many aspects of clinical microbiology, including infectious disease control and epidemiology of pathogens [6, 7].

Even if WGS can be applied to all microorganisms (viruses, bacteria, parasites or fungi), this review focuses on clinical bacteriology. Very good review articles focusing on sequencing technologies or quality control have been published [5, 8, 9]. Herein, we aim to review the applications of WGS in clinical bacteriology focusing on the recent advances in terms of genomic approaches, applications for typing and outbreak, and in silico virulence-associated genes detection and antimicrobial susceptibility prediction for the most common pathogens encountered in blood cultures in our clinical microbiology laboratory [10], as well as for several intracellular bacteria of particular interest (Table 1). For antimicrobial susceptibility prediction based on genomic data, our review is aligned with the in-depth report of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) by Ellington et al. that reviewed the literature on WGS prediction of phenotypic AST from genotypes [11]. We hope that our review will be useful for the clinical microbiologist wishing to obtain an update on the broad applications of WGS for very common pathogens.

Table 1

Items investigated in this review for each pathogen

Items	Pathogens
Genome characteristics	Escherichia coli and other Enterobacteriaceae
Genomic approach	Staphylococcus aureus and coagulase-negative staphylococci
Typing and outbreak	Streptococci and enterococci
Virulence	Pseudomonas aeruginosa and Acinetobacter baumannii
Antimicrobial susceptibility	Mycobacterium tuberculosis complex and other mycobacteria
	Chlamydia trachomatis

Escherichia coli and other Enterobacteriaceae

Genome characteristics

Escherichia coli is one of the most studied organisms in the world. Its genome size ranges from 4.6 Mb to 5.9 Mb for a median GC content of 50.6%, with 4200 to 5500 genes [12]. Overall, Enterobacteriaceae are characterised by a large variable genome with various intra-family horizontal gene transfer (HGT) or recombination, sometimes increased by the host’s medical conditions [13].

Genomic approach

So far, WGS was applied mainly on extracted DNA from cultivated bacterial isolates. However, metagenomic shotgun amplification allowed the identification of foodborne pathogens directly from food samples [14‐16]. Interestingly, Loman et al. used metagenomic shotgun amplification to investigate an outbreak of Shiga toxin-producing E. coli, but sensitivity remained low (67%) compared to cultures [17]. Hasman et al. performed WGS directly on clinical urine samples and successfully identified E. coli, and complete congruence with the regular microbiology work-up was observed [18].

Typing and outbreak

Escherichia coli strains have been historically grouped into serotypes, biotypes, pathotypes and sequence types [12]. Serotypes (O and H antigens), pathotypes and sequence types [like multi-locus sequence typing (MLST) based on 7–8 housekeeping genes] can be inferred from WGS data [12, 19‐21]. Moreover, WGS allows discrimination up to the single nucleotide polymorphisms (SNPs) level for real-time or retrospective investigation of outbreaks of E. coli [22‐25], Salmonella enterica [26‐31] or Klebsiella spp. [32‐35]. Although variants detection allows the most sensitive discrimination between isolates based on DNA sequences, it is limited by the need for a reference genome or whole-genome alignment [36]. Moreover, they lack standardisation and usually do not allow straightforward comparison between studies [20]. New sequence typing methods, such as ribosomal MLST (rMLST, 53 loci) [37], core-genome MLST (cgMLST, >500 loci) or whole-genome MLST (wgMLST, all loci) have arisen since the era of WGS and allow typing up to the strain or clone levels [20]. The use of wgMLST was recently demonstrated by typing extended-spectrum beta-lactamase-producing Enterobacteriaceae [38]. These recent typing tools are available on EnteroBase (https://enterobase.warwick.ac.uk), an online database gathering metadata and genotypes inferred from genome assemblies for four gamma-proteobacteria (Escherichia/Shigella, Salmonella, Yersinia and Moraxella). Moreover, EnteroBase integrates a tool for Salmonella in silico serotyping developed by Yoshida et al. [39]. For K. pneumoniae, a cgMLST scheme was developed to type hypervirulent and multi-resistant strains [40]. Although there is controversy about differentiating the genus Shigella from Escherichia due to its genome similarities with enteroinvasive E. coli [41], a k-mer analysis coupled to MLST from inferred WGS data seems to be an effective discriminative approach [42].

Virulence

Robins-Browne et al. raised the question of the relevance of pathotypes for intestinal pathogenic E. coli (IPEC) in the era of WGS [12]. Although pathotypes remain the subtyping system that is the most clinically relevant, WGS is able to: (i) predict pathotypes with accuracy (Table 2) and (ii) overcome the limitations of this classification, for instance with the emergence of strains with new pathogenic features, such as the enteroaggregative Shiga toxin-producing E. coli [12, 43]. Contrary to the obligate pathogen IPEC, extraintestinal pathogenic E. coli (ExPEC) are opportunistic pathogens and infections arise from the commensal microbiota. Therefore, an identification based on the presence/absence of virulence-associated genes in ExPEC genomes is not straightforward since host medical predispositions also play a major role in the pathogenesis, despite the description of many virulence-associated genes [44]. For K. pneumoniae, several plasmidic and chromosomal genes have been identified as virulence genes associated with community-acquired pyogenic liver abscesses [45, 46]. WGS can identify hypervirulent clones in a rapid manner, which can be of great use to prevent a clonal spread [40, 45, 47].

Table 2

Virulence-associated genetic determinants of the main Escherichia coli pathotypes

Gene/genomic region/plasmid	Functional role	Comments
LEE PAI	Genomic island containing eae (encoding gene for an adhesin) as well as effectors and structural proteins associated with a type III secretion system	EPEC defining region
pINV	Encodes for a type III secretion system and for effectors allowing intracellular survival	EIEC/Shigella defining plasmid
est, elt	Heat-stable (ST) and heat-labile (LT) enterotoxins	ETEC defining genes
stx1, stx2	Shiga toxins (verotoxins) 1 and 2	EHEC defining genes
aggR, aatA, aaiC	Transcriptional regulator, transporter protein and secreted protein	Associated with EAEC phenotype

Adapted from Robins-Browne et al. [12]

LEE PAI, Locus of enterocyte effacement pathogenicity island; EPEC, enteropathogenic E. coli; EIEC, enteroinvasive E. coli; ETEC, enterotoxigenic E. coli; EHEC, enterohaemorrhagic E. coli; EAEC, enteroaggregative E. coli

Antimicrobial susceptibility

Overall, several studies reported more than 95% concordance between genotypic and phenotypic antimicrobial resistances for Enterobacteriaceae, such as E. coli and K. pneumoniae [48‐50]. However, in a significant proportion of carbapenem-resistant K. pneumoniae and E. cloacae isolates, no carbapenemase could be detected, showing the presence of other resistance mechanisms [51]. Indeed, particular resistance mechanisms, such as modification in the membrane permeability or up-regulation of efflux pumps, will be harder to predict, and further studies are required to improve accuracy among heterogeneous datasets [11]. Furthermore, important limitations with short-read technologies remain for plasmid assemblies due to the inability of assemblers to deal with repeats [11]. They can be overcome using long-read sequencing to improve their detection [51‐54] but the cost remains too high for most clinical laboratories. Finally, the particular case of Salmonella spp. needs to be further assessed due to the limited number of studies [11].

Staphylococcus aureus and coagulase-negative staphylococci

Genome characteristics

Staphylococcus aureus has a genome size that ranges from 2.6 to 3.1 Mb, with a median GC content of 32.8%. Coagulase-negative staphylococci (CoNS) have similar genome features to S. aureus. Mobile genetic elements represent 15–20% of the S. aureus genome, emphasising the important transfer of virulence factors and/or antimicrobial resistances that can happen between strains [55] or even between species [56‐58].

Genomic approach

The most common approach for S. aureus is WGS applied on extracted DNA from cultivated bacterial isolates. To our knowledge, no study reported culture-independent genome sequencing. Besides S. aureus, there are a limited number of studies on WGS application for CoNS in a clinical setting.

Typing and outbreak

In terms of discriminatory power, WGS and SNP-based methods overcome all previous methods used for typing, such as pulsed-field gel electrophoresis (PFGE), 7-loci MLST and spa typing [59]. To ensure backward compatibility with traditional genotyping, spa types could be inferred from genome assemblies with 97% [60] and 99.1% [61] accuracy, although spa typing is based on the number and order of repeats, which can theoretically impair reliable genome assemblies from short reads. For SCCmec—a mobile genetic element carrying the methicillin resistance gene in S. aureus [62] that shows a great diversity and a high rate of recombination—typing can also be done using WGS and has the advantage to allow the detection of new types or subtypes, although multiplex polymerase chain reaction (PCR) and DNA microarray remain widely used [63]. During outbreak investigations, many studies could rule in or out a direct transmission of closely related isolates using SNP-based approaches [64‐67]. As for Enterobacteriaceae, rMLST, cgMLST, wgMLST or even pan-genome MLST show high discriminatory power and, if used more often, could be of great use for standardisation and inter-study comparisons [20, 68, 69].

Virulence

Staphylococcus aureus is a highly adapted pathogen and a number of its genes are related to virulence. WGS provides the possibility to screen the genomes for specific genes of interest, such as Panton–Valentine leucocidin (PVL) or superantigens encoding genes (Table 3), involved in severe clinical presentations, such as necrotising pneumonia or staphylococcal toxic shock syndrome [73]. Commercial multiplex PCRs or DNA microarrays are available and can already screen for some antibiotic resistance genes or particular virulence factors in a culture-independent manner. Their clinical utility remains controversial, although some authors recommend the adjunction of a clindamycin regimen for PVL⁺ necrotising pneumonia [73]. Thus, in the context of patient care, the use of WGS for virulence investigation remains limited if not done in a shorter time-to-result. Most of the CoNS virulence-associated genes known are genes related to biofilm or adherence to surface [74]. However, the pro-inflammatory and cytolytic phenol-soluble modulin (PSM) combined with the methicillin resistance island could play a critical role in CoNS sepsis pathogenesis [71].

Table 3

Main Staphylococcus aureus toxins encoded on the accessory genome

Gene/genomic region/plasmid	Functional role	Comments
PVL locus (lukF-PV, lukS-PV)	Pore-forming toxin targeting polymorphonuclear leucocytes	Phage-encoded toxin associated with necrotising pneumonia or severe skin and soft tissue formation
lukD/E, lukG/H	Pore-forming toxins targeting polymorphonuclear leucocytes	Located on a pathogenicity island (LukDE), they act synergistically with PVL
psm-mec locus	Cytolytic capacity, biofilm formation, methicillin resistance, cell spreading and expression of other virulence factors [70]	This locus may also be found in CoNS and could play a major role in CoNS sepsis [71]
eta, etb, etd	Exfoliative toxin A, B and D	Toxins involved in the pathogenesis of bullous impetigo and staphylococcal scaled-skin syndrome
se(a-e), se(g-j), se(r-t), sel(k-q), sel(u-w), tsst-1	Staphylococcal enterotoxins and enterotoxin-like toxins	Superantigens associated with S. aureus food poisoning and toxic shock syndrome

Adapted from Grumann et al. [72]

Antimicrobial susceptibility

Several studies report a high efficiency for in silico antimicrobial susceptibility testing [64, 75‐78]. Mykrobe predictor, an online tool allowing a rapid discrimination between S. aureus and other staphylococci, predicts antimicrobial susceptibility with high sensitivity (99.1%) and specificity (99.6%) [79]. Moreover, the predictions are made from raw sequences and can be achieved in less than 3 min, thanks to a de Bruijn-based method. However, limitations for the antimicrobial susceptibility prediction remain (i) because of gaps in the knowledge and the important number of mechanisms of resistance existing for particular antibiotics such as aminoglycosides or glycopeptides [80, 81], as well as (ii) due to genetic instability with the loss of some mobile genetic elements such as erm(C) or the SCCmec cassette while passaging the isolate [11]. On the other hand, for mupirocin, mismatches between genotypic predictions and AST could be explained by laboratory variations. Indeed, those predicted resistant genotypes concerned isolates with a diameter of inhibition of 29 mm, whereas epidemiological cut-off (ECOFF) for the wild type is more than 30 mm for mupirocin. Therefore, it implies that the mupirocin zone diameter ECOFF needs to be revised [11]. For CoNS, studies comparing genotypic to phenotypic correlation remain limited.

Streptococci and enterococci

Genome characteristics

The median lengths are 1.8 Mb and 2.1 Mb for Streptococcus pyogenes and S. pneumoniae, respectively. Enterococci of medical importance, such as Enterococcus faecalis and E. faecium, have larger genomes, ranging from 2.6 to 3.4 Mb. The GC content for these two genera varies from 35% to 40%. Overall, streptococci and enterococci display high genome plasticity. HGT and homologous recombination can drive serotype modifications, as well as the spread of virulence factors and antibiotic resistance genes [82‐84].

Genomic approach

Regular WGS from bacterial culture is the standard. To our knowledge, no study reports a culture-independent WGS approach for streptococci detection. Hasman et al. could successfully identify E. faecalis by WGS directly from urine samples [18]. In addition, the E. faecalis complete genome sequence could be obtained directly by a metagenomic approach from stool samples by Morowitz et al. [85].

Typing and outbreak

Molecular typing of S. pyogenes is classically done with the M-protein encoding gene (emm), as well as with the 7-loci MLST [86, 87]. However, for outbreak investigation, studies have shown the added value of WGS thanks to its high discriminatory power compared to other typing techniques [88‐91]. Streptococcus pneumoniae serotypes are wildly used and important for epidemiological studies and vaccine development [92]. Interestingly, MLST is highly congruent with strain serotypes [93] and can be easily inferred from WGS data. Serotype prediction from WGS reads is possible thanks to PneumoCaT, a recently developed automated pipeline [94]. It holds the advantage of recognising particular cases of mixed serotypes or in the presence of new subtypes, possibly masked by regular methods. For enterococci, 7-loci MLST and SNP-based approaches are often used for epidemiological studies or outbreak investigations [95‐101]. A cgMLST scheme for E. faecium was recently published by de Been et al. and reaches the same resolution as SNP-based approaches, which could facilitate standardisation and comparisons between laboratories [102].

Virulence

Genomes of streptococci hold many genes related to virulence (Table 4) [103, 105]. However, in addition to the presence or absence of virulence-related genes, mutations in regulators, such as two-component systems, are often involved in increased virulence. Due to the complexity of the paths regulating virulence in streptococci, WGS data could benefit from being combined with RNA sequencing and in vivo study for outbreak investigations [89]. However, we hypothesise that having pipelines and databases of virulence-associated genes and mutations in regulators of virulence would be useful for public health surveillance or to prevent further complications of particular clinical presentations, for example by adding clindamycin to patients at risk of developing toxic shock syndrome for S. pyogenes based on the strain genotype.

Table 4

Main Streptococcus pyogenes virulence factors

Gene/genomic region/plasmid	Functional role	Comments
hasA, hasB, hasC	Hyaluronic acid capsule synthesis	Prevention of phagocytosis
emm	Antiphagocytic protein (M protein)	Sequence used for typing S. pyogenes isolates
spyCEP	Interleukin-8 protease	Inhibition of PMN leucocytes diapedesis
sda1	Streptodornase D (extracellular DNase)	Degradation of PMN DNA nets
sagA, sagB, sagC, slo	Streptolysin S and O	Lysis of red blood cells, epithelial cells, macrophages and PMN
speA, speC, speH, speI, speJ, speL/M, ssa, SMEZ	Superantigens	Involved in the pathogenesis of toxic shock syndrome or scarlet fever
speB	Cysteine protease	Tissue invasion and dissemination
fbaA, sclA	Adhesins

Adapted from Cole et al. [103] and Reglinski and Sriskandan [104]

Many low-/non-virulent isolates hold virulence factors in their genome but their expression is under strong down-regulation. Mutations in two-component systems, such as covR/S or other regulators, have been associated with a dramatic up-regulation of most of those virulence-associated genes

PMN, Polymorphonuclear.

Antimicrobial susceptibility

Many studies focus on antimicrobial resistance and rely to some extent on genomic data [11, 106, 107]. For instance, Howden et al. used WGS to investigate the transmission in hospitalised patients of vancomycin-resistant E. faecium (VREfm), which is, in fact, mainly driven by de novo generation and not only by nosocomial transmission as previously thought [108]. To extend the example of VRE, gene clusters involved in vancomycin resistance in enterococci such as vanA and vanB can be routinely screened using multiplex PCRs with a good correlation with phenotypic AST [109, 110]. By extension, WGS could be used to screen and detect all known van gene clusters. However, to our knowledge, no large studies compared WGS-based genotypic AST to phenotypic AST for streptococci or enterococci, despite the increasing knowledge on the genomic basis of antimicrobial resistances and the rise of multidrug-resistant streptococci and enterococci.

Pseudomonas aeruginosa and Acinetobacter baumannii

Genome characteristics

The P. aeruginosa genome size ranges from 6.1 to 7.5 Mb, with a median GC content of 66.2%. For A. baumannii, its genome size is shorter and varies from 3.7 to 4.3 Mb, with a median GC content of 39%. HGT and genome-wide homologous recombination plays a major role in these two successful and often multidrug-resistant opportunistic pathogens [111‐114]. Plasmid-mediated antibiotic resistances play a major role in the transmission of antimicrobial resistances between isolates and species, which may be hard to assess based only on short reads sequencing, as discussed already for Enterobacteriaceae.

Genomic approach

Most studies that investigated outbreaks used a regular culture-based approach for WGS. Nevertheless, culture-independent shotgun WGS was performed to investigate the composition of the microbiota of sputa sampled from patients with cystic fibrosis, without broad-range 16S rRNA PCR to avoid bias [115].

Typing and outbreak

Recent studies showed the added value of WGS for outbreak investigation retrospectively or prospectively compared to other typing techniques for P. aeruginosa [116‐121] and A. baumannii [122‐126]. Thrane et al. made public a web tool (https://cge.cbs.dtu.dk/services/PAst-1.0/) for in silico determination of the P. aeruginosa serotype, which can be useful to detect or characterise outbreak clones [120]. A real-time WGS investigation of an outbreak in a neonatal intensive care unit was performed and could be used to trace back the index patient and the source of the outbreak [127]. Although it has not been used for P. aeruginosa so far, cgMLST was recently carried out for typing A. baumannii and successfully differentiated a clonal spread among other isolates [128].

Virulence

WGS allowed indubitably a better understanding of acute or chronic P. aeruginosa and A. baumannii infections, and helps the development of new therapeutic approaches [129, 130]. However, besides its use for research or outbreak strain characterisation, a clinical application for the detection of virulence determinants to individualise treatments is currently too preliminary.

Antimicrobial susceptibility

A large study comparing phenotypic and genotypic AST for P. aeruginosa reports 91% sensitivity and 94% specificity for both meropenem- and levofloxacin-resistant phenotypes prediction [131]. However, for amikacin, only 60% of non-susceptible isolates based on AST were congruent with the genomic findings. In contrast, Wright et al. observed high concordance with AST for predicted aminoglycoside and carbapenem susceptibility using 75 isolates of A. baumannii [132]. ARG-ANNOT (Antibiotic Resistance Gene-ANNOTation), a downloadable tool for the detection of antimicrobial resistances, was validated using 174 isolates of A. baumannii with 100% sensitivity and 100% specificity for the genes analysed, even when querying partial sequences [133]. Although good sensitivity/specificity may be reached based on the presence or absence of genes or point mutations in antibiotic target genes, major challenges remain in the prediction of chromosomal alterations, resulting in the modification of expression of genes, such as efflux pumps or intrinsic beta-lactamases [11]. More studies starting from strain collections remain to be done to compare phenotypic and genotypic methods for AST.

Mycobacterium tuberculosis complex and other mycobacteria

Genome characteristics

Mycobacterium tuberculosis complex (MTBC) has a clonal, monomorphic genome of approximately 4.3 to 4.4 Mb. HGT or recombination do not occur in MTBC, whereas it is an important driving force for evolution in other mycobacteria (M. canetti or non-tuberculosis mycobacteria, NTM) [134]. Thus, antimicrobial resistances can only occur from SNPs or insertion–deletion events in MTBC.

Genomic approach

Although many genomic studies have been performed on classical mycobacterial culture, very concrete implementations were attempted in high-income countries [135, 136]. By performing WGS on positive MGIT, a complete report including species identification, in silico AST and calculation of genetic distance to detect outbreaks could be sent a median of 21 days faster than the final reference laboratory report [135]. Moreover, costs were 7% cheaper than the regular workflow for mycobacteria. Public Health England reports to be close to a broad implementation of WGS for the routine diagnosis of mycobacterial infections [137]. Finally, culture-independent WGS was performed directly on sputa. One study performed a proof of concept [138] and the other reported a high-quality sequencing for 20 out of 24 samples and highly concordant genotypic–phenotypic AST [139]. The time-to-AST was 14 days shorter than with other WGS workflows using MGIT. In addition, two sequenced samples did not grow in regular culture, emphasising the added value of WGS performed directly on clinical samples [139].

Typing and outbreak

Recent studies showed a higher resolution of WGS compared to other molecular typing techniques [140‐143], such as restriction fragment length polymorphism (RFLP) [144], spoligotyping [145] or variable-number tandem repeats of mycobacterial interspersed repetitive units (MIRU-VNTR) [146]. Although, spoligotypes and MIRU-VNTR types can be determined from WGS, it is not a straightforward approach due to the repeats in the regions of interest, thus rendering assemblies difficult to make from short reads [147]. For public health, WGS was used to trace back outbreaks with high resolution, giving the possibility to identify clonal transmission between patients [148‐150]. However, as discussed before, SNP-based approaches lack standardisation and inter-laboratory reproducibility. To tackle this issue, a cgMLST scheme was recently designed for MTBC [151].

Virulence

Lessons from M. tuberculosis genomics allowed the identification of a large number of virulence genes, such as catalases, superoxide dismutase, as well as effectors of the type VII secretion system (ESAT-6, CFP10, recently renamed EsxA and EsxB) [152, 153]. However, the relevance to search for specific virulence genes is limited since MTBC populations are mainly clonal and assessment of virulence based on lineages holds more promise. There are seven lineages of MTBC of human health relevance [147]. Lineages 2 (particularly the modern Beijing sublineage) and 4 are the most widespread and are more virulent than lineages 1 and 6, with more severe clinical presentations, more transmissibility and less immunogenicity [154‐157]. Given their restrictive geographic distribution, lineages 3, 5 and 7 are also likely to be less virulent [156]. Thus, knowing lineage informs on virulence and is of public health interest. In addition, automatic web tools can type and assign lineage to a strain from WGS raw data very quickly [158, 159].

Antimicrobial susceptibility

Recent large studies compared AST with the detection of variants associated to antimicrobial resistances [160‐162]. Moreover, several web-based automated tools, taking raw reads as input, are available [79, 158, 159, 163, 164]. Although sensitivity and specificity were high with the dataset used in these studies, the EUCAST study group identified several limitations [11]. (a) Low sensitivity for hetero-resistance is reported for molecular techniques [165] and coverage needs to be increased to overcome that, which, currently, would increase the cost and, thus, may not be suitable for a clinical microbiology laboratory setting. Moreover, most of the current pipelines are not designed to detect insertion–deletion events [166]. (b) Systematic errors may arise from poorly defined cut-offs for phenotypic AST that are used as standard for the validation of in silico AST. (c) Finally, genetic basis for antimicrobial resistance is not completely understood, particularly for non-essential genes involved in antimicrobial resistance, which means that WGS can mainly rule in rather than rule out antimicrobial resistance [11]. However, it is clear that WGS can improve the mycobacterial AST workflow and patient care by reducing dramatically the time to an effective antimicrobial regiment, despite it being unlikely that laboratories will dispense completely with phenotypic AST in the near future [11].

Chlamydia trachomatis

Genome characteristics

Chlamydia trachomatis has a small genome size, as a consequence of the adaptation to its intracellular habitat [167], of 1.0 Mb to 1.1 Mb, with a median GC content of 41.2%. Although there are evidences for HGT and especially for homologous recombination, these mechanisms seem to play a smaller role than point mutations for driving the evolution of C. trachomatis [168].

Genomic approach

Culture-dependant approaches are time- and resource-consuming, due to the intracellular lifestyle of C. trachomatis. To tackle this issue, several studies successfully performed WGS directly on clinical samples by using various techniques: (i) immunomagnetic separation for targeted bacterial enrichment with multiple displacement amplification, (ii) capture RNA bait set, (iii) whole-genome amplification before WGS and (iv) multiplexed microdroplet PCR enrichment technology [169‐172]. A limitation for the clinical use of the first technique could be the lysis buffer, which is present in some commercial devices, and may prevent the binding of antibodies to the major outer membrane protein (MOMP) [173].

Typing and outbreak

Chlamydia trachomatis was historically classified by MOMP-based serology. Serovars are clinically important because they determine the tissue tropism of the infection (serovars A–C, ocular; D–K, urogenital and ocular; L1–L3, lymph nodes) [168]. In recent years, PCR of the ompA, the gene encoding for the MOMP, was developed for typing but exhibited very low epidemiological resolution [174]. The multi-locus variable-number tandem repeat (VNTR) analysis (MLVA) system and various MLST schemes as well as the multi-locus typing DNA array were developed, which provide more reliable topologies [175‐177]. WGS was shown to have a higher resolution than regular phylogenies based on MLST [178].

Virulence

Numerous genes and variants were associated with specific tissue tropism or pathogenic effect [168]. However, besides a straightforward use of WGS to build robust core-genome phylogenies and to infer serovar from ompA to predict tropism, there is currently not enough knowledge on specific virulence factors that could have a clinical value.

Antimicrobial susceptibility

Although treatment failures have been reported, they are not likely due to antimicrobial resistance, which will hopefully remain rare [179]. Thus, there is currently a limited need for in silico antimicrobial resistance predictions for C. trachomatis.

Discussion

For all the major pathogens investigated during this review, we can observe an increasing number of publically available genomes (Fig. 1). Along with this trend, our review shows the development of various WGS-based approaches, as well as attempts of their implementation in a clinical microbiology routine. Knowledge on the genomics of the pathogens is a prerequisite before any clinical use and important features need to be kept in mind for each microorganism. Although horizontal gene transfer or recombination events are very frequent in most pathogens, they do not occur in M. tuberculosis. This is critical because HGT and recombination have a large impact on the transmission of virulence factors, antimicrobial resistance genes and on serovar modifications. Concerning the genomic approaches, WGS is regularly performed on cultivated isolates, but an increasing number of studies report culture-independent WGS, which could speed up the clinical laboratory workflow, particularly to decrease the time to genotypic AST. A straightforward and broadly recognised use of WGS is for the investigation of outbreaks and is nowadays broadly implemented in clinical microbiology and infection control laboratories. Although SNP-based methods have shown great successes, new typing approaches such as rMLST or cgMLST schemes, which offer standardisation and comparability between laboratories, are available for an increasing number of organisms. Moreover, they were shown to be highly reproducible and accurate [180]. Mellmann et al. used cgMLST to monitor prospectively the transmission of methicillin-resistant S. aureus, VRE, multidrug-resistant E. coli and multidrug-resistant P. aeruginosa. This approach was efficient and cost-effective in the setting of a majority of multi-bed rooms and because of the possibility to reduce a systematic isolation recommended by German guidelines [181]. Diseases pathogenesis is extremely diverse and complex. For most pathogens, there is no straightforward approach to predict an isolate’s virulence based on its genotype. Indeed, host factors as well as modification of the expression of virulence-associated genes add another layer of complexity. However, WGS can provide a map of the virulome, which can sometimes be determining for a patient’s care, for instance, by precisely determining the E. coli pathotype. The EUCAST subcommittee reports that there is currently not enough evidence to support clinical decision-making based on genotypic AST [11]. However, for mycobacteria, WGS implementation for diagnosis, in silico AST and outbreak investigation was shown to be successful and cost-effective, with a rapid turnaround time, saving weeks or even months of cultures [135].

Finally, for an implementation in clinical microbiology, WGS-based methods will need standardised and validated (i) procedures, (ii) quality control and (iii) subsequent bioinformatics pipelines. Moreover, they will need to be in line with the clinical requirements for data protection.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt testen ¹

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ²

Didelot X, Bowden R, Wilson DJ et al (2012) Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 13:601–612. doi:10.1038/nrg3226 PubMedPubMedCentralCrossRef

Bertelli C, Greub G (2013) Rapid bacterial genome sequencing: methods and applications in clinical microbiology. Clin Microbiol Infect 19:803–813. doi:10.1111/1469-0691.12217 PubMedCrossRef

Fraser CM, Gocayne JD, White O et al (1995) The minimal gene complement of Mycoplasma genitalium. Science 270:397–404. doi:10.1126/science.270.5235.397 PubMedCrossRef

Fleischmann RD, Adams MD, White O et al (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512PubMedCrossRef

Metzker ML (2010) Sequencing technologies—the next generation. Nat Rev Genet 11:31–46. doi:10.1038/nrg2626 PubMedCrossRef

Loman NJ, Constantinidou C, Chan JZM et al (2012) High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10:599–606. doi:10.1038/nrmicro2850 PubMedCrossRef

Tang P, Croxen MA, Hasan MR et al (2017) Infection control in the new age of genomic epidemiology. Am J Infect Control 45:170–179. doi:10.1016/j.ajic.2016.05.015 PubMedCrossRef

Wain J, Mavrogiorgou E (2013) Next-generation sequencing in clinical microbiology. Expert Rev Mol Diagn 13:225–227. doi:10.1586/erm.13.8 PubMedCrossRef

Gargis AS, Kalman L, Lubin IM (2016) Assuring the quality of next-generation sequencing in clinical microbiology and public health laboratories. J Clin Microbiol 54:2857–2865. doi:10.1128/JCM.00949-16 PubMedPubMedCentralCrossRef

10.

Opota O, Croxatto A, Prod’hom G et al (2015) Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 21:313–322. doi:10.1016/j.cmi.2015.01.003 PubMedCrossRef

11.

Ellington MJ, Ekelund O, Aarestrup FM et al (2017) The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST subcommittee. Clin Microbiol Infect 23:2–22. doi:10.1016/j.cmi.2016.11.012 PubMedCrossRef

12.

Robins-Browne RM, Holt KE, Ingle DJ et al (2016) Are Escherichia coli pathotypes still relevant in the era of whole-genome sequencing? Front Cell Infect Microbiol 6:141. doi:10.3389/fcimb.2016.00141 PubMedPubMedCentralCrossRef

13.

Stecher B, Denzler R, Maier L et al (2012) Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 109:1269–1274. doi:10.1073/pnas.1113246109 PubMedPubMedCentralCrossRef

14.

Leonard SR, Mammel MK, Lacher DW et al (2015) Application of metagenomic sequencing to food safety: detection of Shiga toxin-producing Escherichia coli on fresh bagged spinach. Appl Environ Microbiol 81:8183–8191. doi:10.1128/AEM.02601-15 PubMedPubMedCentralCrossRef

15.

Blagden T, Schneider W, Melcher U et al (2016) Adaptation and validation of E-probe diagnostic nucleic acid analysis for detection of Escherichia coli O157:H7 in metagenomic data from complex food matrices. J Food Prot 79:574–581. doi:10.4315/0362-028X.JFP-15-440 PubMedCrossRef

16.

Leonard SR, Mammel MK, Lacher DW et al (2016) Strain-level discrimination of Shiga toxin-producing Escherichia coli in spinach using metagenomic sequencing. PLoS One 11:e0167870. doi:10.1371/journal.pone.0167870 PubMedPubMedCentralCrossRef

17.

Loman NJ, Constantinidou C, Christner M et al (2013) A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of Shiga-toxigenic Escherichia coli O104:H4. JAMA 309:1502–1510. doi:10.1001/jama.2013.3231 PubMedCrossRef

18.

Hasman H, Saputra D, Sicheritz-Ponten T et al (2014) Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol 52:139–146. doi:10.1128/JCM.02452-13 PubMedPubMedCentralCrossRef

19.

Ingle DJ, Valcanis M, Kuzevski A et al (2016) In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. Microb Genom 2:e000064. doi:10.1099/mgen.0.000064 PubMedPubMedCentral

20.

Maiden MCJ, Jansen van Rensburg MJ, Bray JE et al (2013) MLST revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol 11:728–736. doi:10.1038/nrmicro3093 PubMedPubMedCentralCrossRef

21.

Clermont O, Gordon D, Denamur E (2015) Guide to the various phylogenetic classification schemes for Escherichia coli and the correspondence among schemes. Microbiology 161:980–988. doi:10.1099/mic.0.000063 PubMedCrossRef

22.

Grad YH, Lipsitch M, Feldgarden M et al (2012) Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A 109:3065–3070. doi:10.1073/pnas.1121491109 PubMedPubMedCentralCrossRef

23.

Joensen KG, Scheutz F, Lund O et al (2014) Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol 52:1501–1510. doi:10.1128/JCM.03617-13 PubMedPubMedCentralCrossRef

24.

Rusconi B, Sanjar F, Koenig SSK et al (2016) Whole genome sequencing for genomics-guided investigations of Escherichia coli O157:H7 outbreaks. Front Microbiol 7:985. doi:10.3389/fmicb.2016.00985 PubMedPubMedCentralCrossRef

25.

Mellmann A, Harmsen D, Cummings CA et al (2011) Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6:e22751. doi:10.1371/journal.pone.0022751 PubMedPubMedCentralCrossRef

26.

Quick J, Ashton P, Calus S et al (2015) Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella. Genome Biol 16:114. doi:10.1186/s13059-015-0677-2 PubMedPubMedCentralCrossRef

27.

Byrne L, Fisher I, Peters T et al (2014) A multi-country outbreak of Salmonella Newport gastroenteritis in Europe associated with watermelon from Brazil, confirmed by whole genome sequencing: October 2011 to January 2012. Euro Surveill 19:6–13PubMedPubMedCentralCrossRef

28.

den Bakker HC, Allard MW, Bopp D et al (2014) Rapid whole-genome sequencing for surveillance of Salmonella enterica serovar enteritidis. Emerg Infect Dis 20:1306–1314. doi:10.3201/eid2008.131399 CrossRef

29.

Inns T, Lane C, Peters T et al (2015) A multi-country Salmonella enteritidis phage type 14b outbreak associated with eggs from a German producer: ‘near real-time’ application of whole genome sequencing and food chain investigations, United Kingdom, May to September 2014. Euro Surveill 20(16). pii: 21098

30.

Octavia S, Wang Q, Tanaka MM et al (2015) Delineating community outbreaks of Salmonella enterica serovar Typhimurium by use of whole-genome sequencing: insights into genomic variability within an outbreak. J Clin Microbiol 53:1063–1071. doi:10.1128/JCM.03235-14 PubMedPubMedCentralCrossRef

31.

Phillips A, Sotomayor C, Wang Q et al (2016) Whole genome sequencing of Salmonella typhimurium illuminates distinct outbreaks caused by an endemic multi-locus variable number tandem repeat analysis type in Australia, 2014. BMC Microbiol 16:211. doi:10.1186/s12866-016-0831-3 PubMedPubMedCentralCrossRef

32.

Snitkin ES, Zelazny AM, Thomas PJ et al (2012) Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116. doi:10.1126/scitranslmed.3004129 PubMedPubMedCentralCrossRef

33.

Kanamori H, Parobek CM, Juliano JJ et al (2017) A prolonged outbreak of KPC-3-producing Enterobacter cloacae and Klebsiella pneumoniae driven by multiple mechanisms of resistance transmission at a large academic burn center. Antimicrob Agents Chemother 61(2). pii: e01516-16. doi:10.1128/AAC.01516-16

34.

Zhou K, Lokate M, Deurenberg RH et al (2016) Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum β-lactamase producing ST15 Klebsiella pneumoniae. Sci Rep 6:20840. doi:10.1038/srep20840

35.

Jiang Y, Wei Z, Wang Y et al (2015) Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect 21:1001–1007. doi:10.1016/j.cmi.2015.07.001 PubMedCrossRef

36.

Croucher NJ, Harris SR, Grad YH et al (2013) Bacterial genomes in epidemiology—present and future. Philos Trans R Soc Lond B Biol Sci 368:20120202. doi:10.1098/rstb.2012.0202 PubMedPubMedCentralCrossRef

37.

Jolley KA, Bliss CM, Bennett JS et al (2012) Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology 158:1005–1015. doi:10.1099/mic.0.055459-0 PubMedPubMedCentralCrossRef

38.

Kluytmans-van den Bergh MFQ, Rossen JWA, Bruijning-Verhagen PCJ et al (2016) Whole-genome multilocus sequence typing of extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol 54:2919–2927. doi:10.1128/JCM.01648-16 PubMedPubMedCentralCrossRef

39.

Yoshida CE, Kruczkiewicz P, Laing CR et al (2016) The Salmonella in silico typing resource (SISTR): an open web-accessible tool for rapidly typing and subtyping draft Salmonella genome assemblies. PLoS One 11:e0147101. doi:10.1371/journal.pone.0147101 PubMedPubMedCentralCrossRef

40.

Bialek-Davenet S, Criscuolo A, Ailloud F et al (2014) Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis 20:1812–1820. doi:10.3201/eid2011.140206 PubMedPubMedCentralCrossRef

41.

Pettengill EA, Pettengill JB, Binet R (2016) Phylogenetic analyses of Shigella and enteroinvasive Escherichia coli for the identification of molecular epidemiological markers: whole-genome comparative analysis does not support distinct genera designation. Front Microbiol 6:1573. doi:10.3389/fmicb.2015.01573 PubMedPubMedCentralCrossRef

42.

Chattaway MA, Schaefer U, Tewolde R et al (2017) Identification of Escherichia coli and Shigella species from whole-genome sequences. J Clin Microbiol 55:616–623. doi:10.1128/JCM.01790-16 PubMedPubMedCentralCrossRef

43.

Clements A, Young JC, Constantinou N et al (2012) Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes 3:71–87. doi:10.4161/gmic.19182 PubMedPubMedCentralCrossRef

44.

Köhler C-D, Dobrindt U (2011) What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol 301:642–647. doi:10.1016/j.ijmm.2011.09.006 PubMedCrossRef

45.

Struve C, Roe CC, Stegger M et al (2015) Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio 6:e00630. doi:10.1128/mBio.00630-15 PubMedPubMedCentralCrossRef

46.

Ye M, Tu J, Jiang J et al (2016) Clinical and genomic analysis of liver abscess-causing Klebsiella pneumoniae identifies new liver abscess-associated virulence genes. Front Cell Infect Microbiol 6:165. doi:10.3389/fcimb.2016.00165 PubMedPubMedCentralCrossRef

47.

Holt KE, Wertheim H, Zadoks RN et al (2015) Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A 112:E3574–E3581. doi:10.1073/pnas.1501049112 PubMedPubMedCentralCrossRef

48.

Stoesser N, Batty EM, Eyre DW et al (2013) Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 68:2234–2244. doi:10.1093/jac/dkt180 PubMedPubMedCentralCrossRef

49.

Zankari E, Hasman H, Kaas RS et al (2013) Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J Antimicrob Chemother 68:771–777. doi:10.1093/jac/dks496 PubMedCrossRef

50.

Tyson GH, McDermott PF, Li C et al (2015) WGS accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemother 70:2763–2769. doi:10.1093/jac/dkv186 PubMedCrossRef

51.

Pecora ND, Li N, Allard M et al (2015) Genomically informed surveillance for carbapenem-resistant Enterobacteriaceae in a health care system. MBio 6:e01030-15. doi:10.1128/mBio.01030-15 PubMedPubMedCentralCrossRef

52.

Hudson CM, Bent ZW, Meagher RJ et al (2014) Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain. PLoS One 9:e99209. doi:10.1371/journal.pone.0099209 PubMedPubMedCentralCrossRef

53.

Doi Y, Hazen TH, Boitano M et al (2014) Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing. Antimicrob Agents Chemother 58:5947–5953. doi:10.1128/AAC.03180-14 PubMedPubMedCentralCrossRef

54.

Conlan S, Thomas PJ, Deming C et al (2014) Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 6:254ra126. doi:10.1126/scitranslmed.3009845 PubMedPubMedCentralCrossRef

55.

Lindsay JA (2010) Genomic variation and evolution of Staphylococcus aureus. Int J Med Microbiol 300:98–103. doi:10.1016/j.ijmm.2009.08.013 PubMedCrossRef

56.

Bloemendaal ALA, Brouwer EC, Fluit AC (2010) Methicillin resistance transfer from Staphylocccus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy. PLoS One 5:e11841. doi:10.1371/journal.pone.0011841 PubMedPubMedCentralCrossRef

57.

Zhu W, Clark N, Patel JB (2013) pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro. Antimicrob Agents Chemother 57:212–219. doi:10.1128/AAC.01587-12 PubMedPubMedCentralCrossRef

58.

Zhu W, Murray PR, Huskins WC et al (2010) Dissemination of an Enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54:4314–4320. doi:10.1128/AAC.00185-10 PubMedPubMedCentralCrossRef

59.

Williamson DA, Heffernan H, Nimmo G (2015) Contemporary genomic approaches in the diagnosis and typing of Staphylococcus aureus. Pathology 47:270–275. doi:10.1097/PAT.0000000000000236 PubMedCrossRef

60.

Bartels MD, Petersen A, Worning P et al (2014) Comparing whole-genome sequencing with Sanger sequencing for spa typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 52:4305–4308. doi:10.1128/JCM.01979-14 PubMedPubMedCentralCrossRef

61.

Bletz S, Mellmann A, Rothgänger J et al (2015) Ensuring backwards compatibility: traditional genotyping efforts in the era of whole genome sequencing. Clin Microbiol Infect 21:347.e1–347.e4. doi:10.1016/j.cmi.2014.11.005 CrossRef

62.

International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) (2009) Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 53:4961–4967. doi:10.1128/AAC.00579-09 CrossRef

63.

Liu J, Chen D, Peters BM et al (2016) Staphylococcal chromosomal cassettes mec (SCCmec): a mobile genetic element in methicillin-resistant Staphylococcus aureus. Microb Pathog 101:56–67. doi:10.1016/j.micpath.2016.10.028 PubMedCrossRef

64.

Köser CU, Holden MTG, Ellington MJ et al (2012) Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 366:2267–2275. doi:10.1056/NEJMoa1109910 PubMedPubMedCentralCrossRef

65.

Azarian T, Cook RL, Johnson JA et al (2015) Whole-genome sequencing for outbreak investigations of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice? Infect Control Hosp Epidemiol 36:777–785. doi:10.1017/ice.2015.73 PubMedPubMedCentralCrossRef

66.

Layer F, Sanchini A, Strommenger B et al (2015) Molecular typing of toxic shock syndrome toxin-1- and enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit. Int J Med Microbiol 305:790–798. doi:10.1016/j.ijmm.2015.08.033 PubMedCrossRef

67.

Jaton L, Pillonel T, Jaton K et al (2016) Common skin infection due to Panton–Valentine leucocidin-producing Staphylococcus aureus strains in asylum seekers from Eritrea: a genome-based investigation of a suspected outbreak. Clin Microbiol Infect 22:739.e5–739.e8. doi:10.1016/j.cmi.2016.05.026 CrossRef

68.

Leopold SR, Goering RV, Witten A et al (2014) Bacterial whole-genome sequencing revisited: portable, scalable, and standardized analysis for typing and detection of virulence and antibiotic resistance genes. J Clin Microbiol 52:2365–2370. doi:10.1128/JCM.00262-14 PubMedPubMedCentralCrossRef

69.

Roisin S, Gaudin C, De Mendonça R et al (2016) Pan-genome multilocus sequence typing and outbreak-specific reference-based single nucleotide polymorphism analysis to resolve two concurrent Staphylococcus aureus outbreaks in neonatal services. Clin Microbiol Infect 22:520–526. doi:10.1016/j.cmi.2016.01.024 PubMedCrossRef

70.

Qin L, McCausland JW, Cheung GYC et al (2016) PSM-mec—a virulence determinant that connects transcriptional regulation, virulence, and antibiotic resistance in staphylococci. Front Microbiol 7:1293. doi:10.3389/fmicb.2016.01293 PubMedPubMedCentral

71.

Qin L, Da F, Fisher EL et al (2017) Toxin mediates sepsis caused by methicillin-resistant Staphylococcus epidermidis. PLoS Pathog 13:e1006153. doi:10.1371/journal.ppat.1006153 PubMedPubMedCentralCrossRef

72.

Grumann D, Nübel U, Bröker BM (2014) Staphylococcus aureus toxins—their functions and genetics. Infect Genet Evol 21:583–592. doi:10.1016/j.meegid.2013.03.013 PubMedCrossRef

73.

Tong SYC, Davis JS, Eichenberger E et al (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603–661. doi:10.1128/CMR.00134-14 PubMedPubMedCentralCrossRef

74.

Becker K, Heilmann C, Peters G (2014) Coagulase-negative staphylococci. Clin Microbiol Rev 27:870–926. doi:10.1128/CMR.00109-13 PubMedPubMedCentralCrossRef

75.

Eyre DW, Golubchik T, Gordon NC et al (2012) A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2:e001124. doi:10.1136/bmjopen-2012-001124 PubMedPubMedCentralCrossRef

76.

Holden MTG, Hsu L-Y, Kurt K et al (2013) A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 23:653–664. doi:10.1101/gr.147710.112 PubMedPubMedCentralCrossRef

77.

Gordon NC, Price JR, Cole K et al (2014) Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J Clin Microbiol 52:1182–1191. doi:10.1128/JCM.03117-13 PubMedPubMedCentralCrossRef

78.

Lee GC, Long SW, Musser JM et al (2015) Comparative whole genome sequencing of community-associated methicillin-resistant Staphylococcus aureus sequence type 8 from primary care clinics in a Texas community. Pharmacotherapy 35:220–228. doi:10.1002/phar.1536 PubMedCrossRef

79.

Bradley P, Gordon NC, Walker TM et al (2015) Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nat Commun 6:10063. doi:10.1038/ncomms10063 PubMedPubMedCentralCrossRef

80.

Chen C-J, Huang Y-C, Chiu C-H (2015) Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia. J Antimicrob Chemother 70:2965–2972. doi:10.1093/jac/dkv225 PubMedCrossRef

81.

McEvoy CRE, Tsuji B, Gao W et al (2013) Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression. Antimicrob Agents Chemother 57:3240–3249. doi:10.1128/AAC.00279-13 PubMedPubMedCentralCrossRef

82.

Andam CP, Hanage WP (2015) Mechanisms of genome evolution of Streptococcus. Infect Genet Evol 33:334–342. doi:10.1016/j.meegid.2014.11.007 PubMedCrossRef

83.

Hegstad K, Mikalsen T, Coque TM et al (2010) Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin Microbiol Infect 16:541–554. doi:10.1111/j.1469-0691.2010.03226.x PubMedCrossRef

84.

Croucher NJ, Harris SR, Fraser C et al (2011) Rapid pneumococcal evolution in response to clinical interventions. Science 331:430–434. doi:10.1126/science.1198545 PubMedPubMedCentralCrossRef

85.

Morowitz MJ, Denef VJ, Costello EK et al (2011) Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci U S A 108:1128–1133. doi:10.1073/pnas.1010992108 PubMedCrossRef

86.

Sanderson-Smith M, De Oliveira DM, Guglielmini J et al (2014) A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis 210:1325–1338. doi:10.1093/infdis/jiu260 PubMedCrossRef

87.

Bessen DE, McShan WM, Nguyen SV et al (2015) Molecular epidemiology and genomics of group A Streptococcus. Infect Genet Evol 33:393–418. doi:10.1016/j.meegid.2014.10.011 PubMedCrossRef

88.

Ben Zakour NL, Venturini C, Beatson SA et al (2012) Analysis of a Streptococcus pyogenes puerperal sepsis cluster by use of whole-genome sequencing. J Clin Microbiol 50:2224–2228. doi:10.1128/JCM.00675-12 PubMedPubMedCentralCrossRef

89.

Olsen RJ, Fittipaldi N, Kachroo P et al (2014) Clinical laboratory response to a mock outbreak of invasive bacterial infections: a preparedness study. J Clin Microbiol 52:4210–4216. doi:10.1128/JCM.02164-14 PubMedPubMedCentralCrossRef

90.

Engelthaler DM, Valentine M, Bowers J et al (2016) Hypervirulent emm59 clone in invasive group A Streptococcus outbreak, southwestern United States. Emerg Infect Dis 22:734–738. doi:10.3201/eid2204.151582 PubMedPubMedCentralCrossRef

91.

Tagini F, Aubert B, Troillet N et al (2017) Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-017-2905-z

92.

Jauneikaite E, Tocheva AS, Jefferies JMC et al (2015) Current methods for capsular typing of Streptococcus pneumoniae. J Microbiol Methods 113:41–49. doi:10.1016/j.mimet.2015.03.006 PubMedCrossRef

93.

Harrison OB, Brueggemann AB, Caugant DA et al (2011) Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology 157:2181–2195. doi:10.1099/mic.0.050518-0 PubMedPubMedCentralCrossRef

94.

Kapatai G, Sheppard CL, Al-Shahib A et al (2016) Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline. PeerJ 4:e2477. doi:10.7717/peerj.2477 PubMedPubMedCentralCrossRef

95.

Lister DM, Kotsanas D, Ballard SA et al (2015) Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service. Am J Infect Control 43:1061–1065. doi:10.1016/j.ajic.2015.05.047 PubMedCrossRef

96.

Sivertsen A, Billström H, Melefors Ö et al (2014) A multicentre hospital outbreak in Sweden caused by introduction of a vanB2 transposon into a stably maintained pRUM-plasmid in an Enterococcus faecium ST192 clone. PLoS One 9:e103274. doi:10.1371/journal.pone.0103274 PubMedPubMedCentralCrossRef

97.

Schlebusch S, Price GR, Gallagher RL et al (2017) MALDI-TOF MS meets WGS in a VRE outbreak investigation. Eur J Clin Microbiol Infect Dis 36:495–499. doi:10.1007/s10096-016-2824-4 PubMedCrossRef

98.

Brodrick HJ, Raven KE, Harrison EM et al (2016) Whole-genome sequencing reveals transmission of vancomycin-resistant Enterococcus faecium in a healthcare network. Genome Med 8:4. doi:10.1186/s13073-015-0259-7 PubMedPubMedCentralCrossRef

99.

Raven KE, Reuter S, Reynolds R et al (2016) A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland. Genome Res 26:1388–1396. doi:10.1101/gr.204024.116 PubMedPubMedCentralCrossRef

100.

Raven KE, Reuter S, Gouliouris T et al (2016) Genome-based characterization of hospital-adapted Enterococcus faecalis lineages. Nat Microbiol 1(3). pii: 15033. doi:10.1038/nmicrobiol.2015.33

101.

Santona A, Taviani E, Deligios M et al (2016) Vancomycin-resistant Enterococcus faecium high-resolution typing by core genome multilocus sequence typing. J Infect Dev Ctries 10:1159–1161. doi:10.3855/jidc.9223 PubMedCrossRef

102.

de Been M, Pinholt M, Top J et al (2015) Core genome multilocus sequence typing scheme for high-resolution typing of Enterococcus faecium. J Clin Microbiol 53:3788–3797. doi:10.1128/JCM.01946-15 PubMedPubMedCentralCrossRef

103.

Cole JN, Barnett TC, Nizet V et al (2011) Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 9:724–736. doi:10.1038/nrmicro2648 PubMedCrossRef

104.

Reglinski M, Sriskandan S (2014) The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis. Virulence 5:127–136. doi:10.4161/viru.26400

105.

Mitchell AM, Mitchell TJ (2010) Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect 16:411–418. doi:10.1111/j.1469-0691.2010.03183.x

106.

Cattoir V (2016) Mechanisms of antibiotic resistance: Streptococcus pyogenes. In: Ferretti JJ, Stevens DL, Fischetti VA (eds) Streptococcus pyogenes: basic biology to clinical manifestations. University of Oklahoma Health Sciences Center, Oklahoma City, pp 947–991

107.

Miller WR, Munita JM, Arias CA (2014) Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 12:1221–1236. doi:10.1586/14787210.2014.956092 PubMedPubMedCentralCrossRef

108.

Howden BP, Holt KE, Lam MMC et al (2013) Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio 4:e00412-13. doi:10.1128/mBio.00412-13 PubMedPubMedCentralCrossRef

109.

Holzknecht BJ, Hansen DS, Nielsen L et al (2017) Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making. New Microbes New Infect 16:54–59. doi:10.1016/j.nmni.2016.12.020 PubMedPubMedCentralCrossRef

110.

Huh HJ, Jang M-A, Seo JY et al (2015) Evaluation of the iNtRON VRE vanA/vanB real-time PCR assay for detection of vancomycin-resistant enterococci. Ann Lab Med 35:76–81. doi:10.3343/alm.2015.35.1.76 PubMedCrossRef

111.

Klockgether J, Cramer N, Wiehlmann L et al (2011) Pseudomonas aeruginosa genomic structure and diversity. Front Microbiol 2:150. doi:10.3389/fmicb.2011.00150 PubMedPubMedCentralCrossRef

112.

Dettman JR, Rodrigue N, Kassen R (2014) Genome-wide patterns of recombination in the opportunistic human pathogen Pseudomonas aeruginosa. Genome Biol Evol 7:18–34. doi:10.1093/gbe/evu260 PubMedPubMedCentralCrossRef

113.

Antunes LCS, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71:292–301. doi:10.1111/2049-632X.12125 PubMedCrossRef

114.

Touchon M, Cury J, Yoon E-J et al (2014) The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences. Genome Biol Evol 6:2866–2882. doi:10.1093/gbe/evu225 PubMedPubMedCentralCrossRef

115.

Hauser PM, Bernard T, Greub G et al (2014) Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencing. PLoS One 9:e90934. doi:10.1371/journal.pone.0090934 PubMedPubMedCentralCrossRef

116.

Snyder LA, Loman NJ, Faraj LA et al (2013) Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing. Euro Surveill 18:20611PubMedCrossRef

117.

Witney AA, Gould KA, Pope CF et al (2014) Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa. Clin Microbiol Infect 20:O609–O618. doi:10.1111/1469-0691.12528 PubMedCrossRef

118.

Turton JF, Wright L, Underwood A et al (2015) High-resolution analysis by whole-genome sequencing of an international lineage (sequence type 111) of Pseudomonas aeruginosa associated with metallo-carbapenemases in the United Kingdom. J Clin Microbiol 53:2622–2631. doi:10.1128/JCM.00505-15 PubMedPubMedCentralCrossRef

119.

Willmann M, Bezdan D, Zapata L et al (2015) Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study. J Antimicrob Chemother 70:1322–1330. doi:10.1093/jac/dku546 PubMedCrossRef

120.

Thrane SW, Taylor VL, Lund O et al (2016) Application of whole-genome sequencing data for O-specific antigen analysis and in silico serotyping of Pseudomonas aeruginosa isolates. J Clin Microbiol 54:1782–1788. doi:10.1128/JCM.00349-16 PubMedPubMedCentralCrossRef

121.

Blanc DS, Gomes Magalhaes B, Abdelbary M et al (2016) Hand soap contamination by Pseudomonas aeruginosa in a tertiary care hospital: no evidence of impact on patients. J Hosp Infect 93:63–67. doi:10.1016/j.jhin.2016.02.010 PubMedCrossRef

122.

Lewis T, Loman NJ, Bingle L et al (2010) High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 75:37–41. doi:10.1016/j.jhin.2010.01.012 PubMedCrossRef

123.

Halachev MR, Chan JZ-M, Constantinidou CI et al (2014) Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England. Genome Med 6:70. doi:10.1186/s13073-014-0070-x PubMedPubMedCentralCrossRef

124.

Salipante SJ, SenGupta DJ, Cummings LA et al (2015) Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol 53:1072–1079. doi:10.1128/JCM.03385-14 PubMedPubMedCentralCrossRef

125.

Hammerum AM, Hansen F, Skov MN et al (2015) Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs. J Antimicrob Chemother 70:1965–1968. doi:10.1093/jac/dkv072 PubMed

126.

Fitzpatrick MA, Ozer EA, Hauser AR (2016) Utility of whole-genome sequencing in characterizing Acinetobacter epidemiology and analyzing hospital outbreaks. J Clin Microbiol 54:593–612. doi:10.1128/JCM.01818-15 PubMedPubMedCentralCrossRef

127.

Davis RJ, Jensen SO, Van Hal S et al (2015) Whole genome sequencing in real-time investigation and management of a Pseudomonas aeruginosa outbreak on a neonatal intensive care unit. Infect Control Hosp Epidemiol 36:1058–1064. doi:10.1017/ice.2015.133 PubMedCrossRef

128.

Willems S, Kampmeier S, Bletz S et al (2016) Whole-genome sequencing elucidates epidemiology of nosocomial clusters of Acinetobacter baumannii. J Clin Microbiol 54:2391–2394. doi:10.1128/JCM.00721-16 PubMedPubMedCentralCrossRef

129.

Fothergill JL, Winstanley C, James CE (2012) Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Expert Rev Anti Infect Ther 10:219–235. doi:10.1586/eri.11.168 PubMedCrossRef

130.

Wang N, Ozer EA, Mandel MJ et al (2014) Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. MBio 5:e01163-14. doi:10.1128/mBio.01163-14 PubMedPubMedCentralCrossRef

131.

Kos VN, Déraspe M, McLaughlin RE et al (2015) The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 59:427–436. doi:10.1128/AAC.03954-14 PubMedCrossRef

132.

Wright MS, Stockwell TB, Beck E et al (2015) SISPA-Seq for rapid whole genome surveys of bacterial isolates. Infect Genet Evol 32:191–198. doi:10.1016/j.meegid.2015.03.018 PubMedPubMedCentralCrossRef

133.

Gupta SK, Padmanabhan BR, Diene SM et al (2014) ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 58:212–220. doi:10.1128/AAC.01310-13 PubMedPubMedCentralCrossRef

134.

Boritsch EC, Khanna V, Pawlik A et al (2016) Key experimental evidence of chromosomal DNA transfer among selected tuberculosis-causing mycobacteria. Proc Natl Acad Sci U S A 113:9876–9881. doi:10.1073/pnas.1604921113 PubMedPubMedCentralCrossRef

135.

Pankhurst LJ, Del Ojo Elias C, Votintseva AA et al (2016) Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med 4:49–58. doi:10.1016/S2213-2600(15)00466-X PubMedPubMedCentralCrossRef

136.

Cirillo DM, Cabibbe AM, De Filippo MR et al (2016) Use of WGS in Mycobacterium tuberculosis routine diagnosis. Int J Mycobacteriol 5(Suppl 1):S252–S253. doi:10.1016/j.ijmyco.2016.09.053 PubMedCrossRef

137.

Public Health England (2016) Tuberculosis in England: 2016 report. Available online at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/581238/TB_Annual_Report_2016_GTW2309_errata_v1.2.pdf. Accessed 21 Feb 2017

138.

Doughty EL, Sergeant MJ, Adetifa I et al (2014) Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer. PeerJ 2:e585. doi:10.7717/peerj.585 PubMedPubMedCentralCrossRef

139.

Brown AC, Bryant JM, Einer-Jensen K et al (2015) Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples. J Clin Microbiol 53:2230–2237. doi:10.1128/JCM.00486-15 PubMedPubMedCentralCrossRef

140.

Jamieson FB, Teatero S, Guthrie JL et al (2014) Whole-genome sequencing of the Mycobacterium tuberculosis Manila sublineage results in less clustering and better resolution than mycobacterial interspersed repetitive-unit–variable-number tandem-repeat (MIRU-VNTR) typing and spoligotyping. J Clin Microbiol 52:3795–3798. doi:10.1128/JCM.01726-14 PubMedPubMedCentralCrossRef

141.

Luo T, Yang C, Peng Y et al (2014) Whole-genome sequencing to detect recent transmission of Mycobacterium tuberculosis in settings with a high burden of tuberculosis. Tuberculosis (Edinb) 94:434–440. doi:10.1016/j.tube.2014.04.005 CrossRef

142.

Mehaffy C, Guthrie JL, Alexander DC et al (2014) Marked microevolution of a unique Mycobacterium tuberculosis strain in 17 years of ongoing transmission in a high risk population. PLoS One 9:e112928. doi:10.1371/journal.pone.0112928 PubMedPubMedCentralCrossRef

143.

Roetzer A, Diel R, Kohl TA et al (2013) Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 10:e1001387. doi:10.1371/journal.pmed.1001387 PubMedPubMedCentralCrossRef

144.

Otal I, Martín C, Vincent-Lévy-Frebault V et al (1991) Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis. J Clin Microbiol 29:1252–1254PubMedPubMedCentral

145.

Kamerbeek J, Schouls L, Kolk A et al (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35:907–914PubMedPubMedCentral

146.

Supply P, Lesjean S, Savine E et al (2001) Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 39:3563–3571. doi:10.1128/JCM.39.10.3563-3571.2001 PubMedPubMedCentralCrossRef

147.

Takiff HE, Feo O (2015) Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. Lancet Infect Dis 15:1077–1090. doi:10.1016/S1473-3099(15)00071-7 PubMedCrossRef

148.

Gardy JL, Johnston JC, Ho Sui SJ et al (2011) Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364:730–739. doi:10.1056/NEJMoa1003176 PubMedCrossRef

149.

Walker TM, Ip CL, Harrell RH et al (2013) Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13:137–146. doi:10.1016/S1473-3099(12)70277-3 PubMedPubMedCentralCrossRef

150.

Stucki D, Ballif M, Bodmer T et al (2015) Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. J Infect Dis 211:1306–1316. doi:10.1093/infdis/jiu601 PubMedCrossRef

151.

Kohl TA, Diel R, Harmsen D et al (2014) Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach. J Clin Microbiol 52:2479–2486. doi:10.1128/JCM.00567-14 PubMedPubMedCentralCrossRef

152.

Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544. doi:10.1038/31159 PubMedCrossRef

153.

Forrellad MA, Klepp LI, Gioffré A et al (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4:3–66. doi:10.4161/viru.22329 PubMedPubMedCentralCrossRef

154.

Hanekom M, van der Spuy GD, Streicher E et al (2007) A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol 45:1483–1490. doi:10.1128/JCM.02191-06 PubMedPubMedCentralCrossRef

155.

Ribeiro SCM, Gomes LL, Amaral EP et al (2014) Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage. J Clin Microbiol 52:2615–2624. doi:10.1128/JCM.00498-14 PubMedPubMedCentralCrossRef

156.

Coscolla M, Gagneux S (2014) Consequences of genomic diversity in Mycobacterium tuberculosis. Semin Immunol 26:431–444. doi:10.1016/j.smim.2014.09.012 PubMedPubMedCentralCrossRef

157.

Liu Q, Luo T, Dong X et al (2016) Genetic features of Mycobacterium tuberculosis modern Beijing sublineage. Emerg Microbes Infect 5:e14. doi:10.1038/emi.2016.14 PubMedPubMedCentralCrossRef

158.

Feuerriegel S, Schleusener V, Beckert P et al (2015) PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data. J Clin Microbiol 53:1908–1914. doi:10.1128/JCM.00025-15 PubMedPubMedCentralCrossRef

159.

Iwai H, Kato-Miyazawa M, Kirikae T et al (2015) CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): a publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates. Tuberculosis (Edinb) 95:843–844. doi:10.1016/j.tube.2015.09.002 CrossRef

160.

Zhang H, Li D, Zhao L et al (2013) Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 45:1255–1260. doi:10.1038/ng.2735 PubMedCrossRef

161.

Köser CU, Bryant JM, Becq J et al (2013) Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med 369:290–292. doi:10.1056/NEJMc1215305 PubMedCrossRef

162.

Walker TM, Kohl TA, Omar SV et al (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15:1193–1202. doi:10.1016/S1473-3099(15)00062-6 PubMedPubMedCentralCrossRef

163.

Coll F, McNerney R, Preston MD et al (2015) Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med 7:51. doi:10.1186/s13073-015-0164-0 PubMedPubMedCentralCrossRef

164.

Steiner A, Stucki D, Coscolla M et al (2014) KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes. BMC Genomics 15:881. doi:10.1186/1471-2164-15-881 PubMedPubMedCentralCrossRef

165.

Folkvardsen DB, Thomsen VØ, Rigouts L et al (2013) Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods. J Clin Microbiol 51:4220–4222. doi:10.1128/JCM.01602-13 PubMedPubMedCentralCrossRef

166.

Loman NJ, Pallen MJ (2015) Twenty years of bacterial genome sequencing. Nat Rev Microbiol 13:787–794PubMedCrossRef

167.

Zomorodipour A, Andersson SG (1999) Obligate intracellular parasites: Rickettsia prowazekii and Chlamydia trachomatis. FEBS Lett 452:11–15. doi:10.1016/S0014-5793(99)00563-3 PubMedCrossRef

168.

Nunes A, Borrego MJ, Gomes JP (2013) Genomic features beyond Chlamydia trachomatis phenotypes: what do we think we know? Infect Genet Evol 16:392–400. doi:10.1016/j.meegid.2013.03.018 PubMedCrossRef

169.

Seth-Smith HMB, Harris SR, Skilton RJ et al (2013) Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res 23:855–866. doi:10.1101/gr.150037.112 PubMedPubMedCentralCrossRef

170.

Christiansen MT, Brown AC, Kundu S et al (2014) Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples. BMC Infect Dis 14:591. doi:10.1186/s12879-014-0591-3 PubMedPubMedCentralCrossRef

171.

Andersson P, Klein M, Lilliebridge RA et al (2013) Sequences of multiple bacterial genomes and a Chlamydia trachomatis genotype from direct sequencing of DNA derived from a vaginal swab diagnostic specimen. Clin Microbiol Infect 19:E405–E408. doi:10.1111/1469-0691.12237 PubMedCrossRef

172.

Joseph SJ, Li B, Ghonasgi T et al (2014) Direct amplification, sequencing and profiling of Chlamydia trachomatis strains in single and mixed infection clinical samples. PLoS One 9:e99290. doi:10.1371/journal.pone.0099290 PubMedPubMedCentralCrossRef

173.

de Vries HJC, Schim van der Loeff MF, Bruisten SM (2015) High-resolution typing of Chlamydia trachomatis: epidemiological and clinical uses. Curr Opin Infect Dis 28:61–71. doi:10.1097/QCO.0000000000000129 PubMedCrossRef

174.

Pedersen LN, Herrmann B, Møller JK (2009) Typing Chlamydia trachomatis: from egg yolk to nanotechnology. FEMS Immunol Med Microbiol 55:120–130. doi:10.1111/j.1574-695X.2008.00526.x PubMedCrossRef

175.

Klint M, Fuxelius H-H, Goldkuhl RR et al (2007) High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol 45:1410–1414. doi:10.1128/JCM.02301-06 PubMedPubMedCentralCrossRef

176.

Pedersen LN, Pødenphant L, Møller JK (2008) Highly discriminative genotyping of Chlamydia trachomatis using omp1 and a set of variable number tandem repeats. Clin Microbiol Infect 14:644–652. doi:10.1111/j.1469-0691.2008.02011.x PubMedCrossRef

177.

Labiran C, Clarke IN, Cutcliffe LT et al (2012) Genotyping markers used for multi locus VNTR analysis with ompA (MLVA-ompA) and multi sequence typing (MST) retain stability in Chlamydia trachomatis. Front Cell Infect Microbiol 2:68. doi:10.3389/fcimb.2012.00068 PubMedPubMedCentralCrossRef

178.

Harris SR, Clarke IN, Seth-Smith HMB et al (2012) Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet 44:413–419. doi:10.1038/ng.2214 PubMedPubMedCentralCrossRef

179.

Kong FYS, Hocking JS (2015) Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis 15:293. doi:10.1186/s12879-015-1030-9 PubMedPubMedCentralCrossRef

180.

Mellmann A, Andersen PS, Bletz S et al (2017) High interlaboratory reproducibility and accuracy of next-generation-sequencing-based bacterial genotyping in a ring trial. J Clin Microbiol 55:908–913. doi:10.1128/JCM.02242-16 PubMedPubMedCentralCrossRef

181.

Mellmann A, Bletz S, Böking T et al (2016) Real-time genome sequencing of resistant bacteria provides precision infection control in an institutional setting. J Clin Microbiol 54:2874–2881. doi:10.1128/JCM.00790-16 PubMedPubMedCentralCrossRef

Titel: Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review
verfasst von: F. Tagini
G. Greub
Publikationsdatum: 21.06.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-3024-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Escherichia coli and other Enterobacteriaceae

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Staphylococcus aureus and coagulase-negative staphylococci

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Streptococci and enterococci

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Pseudomonas aeruginosa and Acinetobacter baumannii

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Mycobacterium tuberculosis complex and other mycobacteria

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Chlamydia trachomatis

Genome characteristics

Genomic approach

Typing and outbreak

Virulence

Antimicrobial susceptibility

Discussion

Compliance with ethical standards

Conflict of interest

Unsere Produktempfehlungen

e.Med Interdisziplinär

e.Med Innere Medizin

Weitere Artikel der Ausgabe 11/2017

Mobile health clinic for the medical management of clinical sequelae experienced by survivors of the 2013–2016 Ebola virus disease outbreak in Sierra Leone, West Africa

Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil

Nasopharyngeal pertussis toxin IgA antibodies in the diagnosis of pertussis in Australian community patients

Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study

Blastocystis in Côte d’Ivoire: molecular identification and epidemiological data

Performance of microbial identification by MALDI-TOF MS and susceptibility testing by VITEK 2 from positive blood cultures after minimal incubation on solid media

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin